Products
The QIAstat-Dx Analyzer and QIAstat-Dx Panels are intended for in vitro diagnostic use.
Product availability may differ from country to country based on regulations and approvals. Contact your country representative for further details.
This product contains substances regulated under REACH (EC 1907/2006 Annex XIV). The use of this product in the EU is permitted subject to an exemption (Article 56(3)). Please refer to the REACH notification and the SDS of this product, both of which can be found in the “Resources” section of this page, for more information.
The QIAstat-Dx Meningitis/Encephalitis (ME) Panel is indicated as an aid in the diagnosis of specific agents that cause meningitis and/or encephalitis, and results must be used in conjunction with other clinical, epidemiological, and laboratory data. Results from the QIAstat-Dx ME Panel are not intended to be used as the sole basis for diagnosis, treatment, or other patient management decisions. Positive results do not rule out co-infection with organisms not included in the QIAstat-Dx ME Panel. The agent or agents detected may not be the definite cause of the disease. Negative results do not preclude central nervous system (CNS) infection. The QIAstat-Dx ME Panel is intended for in vitro diagnostic use by laboratory professionals only.
This product contains substances regulated under REACH (EC 1907/2006 Annex XIV). The use of this product in the EU is permitted subject to an exemption (Article 56(3)). Please refer to the REACH notification and the SDS of this product, both of which can be found in the “Resources” section of this page, for more information.
This product contains substances regulated under REACH (EC 1907/2006 Annex XIV). The use of this product in the EU is permitted subject to an exemption (Article 56(3)). Please refer to the REACH notification and the SDS of this product, both of which can be found in the “Resources” section of this page, for more information.
This product contains substances regulated under REACH (EC 1907/2006 Annex XIV). The use of this product in the EU is permitted subject to an exemption (Article 56(3)). Please refer to the REACH notification and the SDS of this product, both of which can be found in the “Resources” section of this page, for more information.
Features
- Intuitive workflow with minimal hands-on time
- Uses real-time PCR to deliver comprehensive results in about an hour
- Easily view Ct values and amplification curves for all detected pathogens
- No precision pipetting required and unique direct swab protocol for input into the cartridge
- QIAsphere-connected for real-time updates, proactive remote service and custom epidemiology reports
Product Details
QIAstat-Dx simplifies infectious disease diagnostics so you can get faster results for your patients. All you need are a patient sample, a QIAstat-Dx assay cartridge and our intuitive QIAstat-Dx instrument.
The QIAstat-Dx assay cartridges use multiplex PCR technology – also known as syndromic testing – to quickly survey many different pathogens in a single patient sample. The cartridges come ready with all reagents preloaded and use our trusted assay chemistry to provide comprehensive results in about an hour.
The QIAstat-Dx Analyzer is our flexible modular system, perfect for labs of every size. Each instrument is made up of 1 Operational Module, which contains the intuitive touch-screen interface, and between 1 through 4 Analytical Modules, letting you test up to four samples at once. The QIAstat-Dx Analyzer condenses dozens of pathogen real-time PCR tests into one small benchtop unit.
You’ll save even more time with QIAstat-Dx connectivity, powered by QIAsphere*. With QIAstat-Dx connectivity, you can remotely monitor your instruments in real-time, receive proactive technical support and get on-demand epidemiology reports to support your institution-wide surveillance efforts. Simply install the QIAsphere app on your preferred tablet or smartphone or by accessing the QIAsphere web app through your laptop or desktop browser.
Visit our resource hub to learn how syndromic testing with QIAstat-Dx can help you provide the best care possible for your patients.
Principle
The QIAstat-Dx Analyzer, combined with QIAstat-Dx assay cartridges, uses real-time PCR to detect pathogen nucleic acids in human biological samples. The QIAstat-Dx Analyzer and cartridges are designed as a closed system that contains on board all necessary reagents, enabling hands-off sample preparation. Detected real-time amplification signals are interpreted by the integrated software and are reported via an intuitive user interface.
Procedure
Setting up and running a QIAstat-Dx test requires minimal hands-on time and just a few simple steps.
- Add the patient sample to the main port of the QIAstat-Dx cartridge using the plastic pipette provided. For our respiratory panels, you can alternatively apply the sample with a dry swab. This step is fast and easy to perform and requires no precision pipetting.
- Press the Run Test button on the QIAstat-Dx touch screen and scan the sample ID barcode.
- Scan the barcode of the cartridge you’re using.
- Position the cartridge on the instrument’s sample port. The cartridge will automatically move in and the test will start.
- After about an hour, view the comprehensive results.
Applications
QIAstat-Dx Respiratory SARS-CoV-2 Panel: Qualitative test to analyze 23 viral and bacterial respiratory targets for common pathogens causing respiratory infections, including SARS-CoV-2.
| QIAstat-Dx Respiratory SARS-CoV-2 Panel – 23 bacterial and viral targets | ||
|---|---|---|
| Viruses | Bacteria | |
|
Influenza A Influenza A subtype H1N1/2009 Influenza A subtype H1 Influenza A subtype H3 Influenza B Coronavirus 229E Coronavirus HKU1 Coronavirus NL63 Coronavirus OC43 SARS-CoV-2 |
Parainfluenza virus 1 Parainfluenza virus 2 Parainfluenza virus 3 Parainfluenza virus 4 Respiratory syncytial virus A/B Human metapneumovirus A/B Adenovirus Bocavirus Rhinovirus/Enterovirus** |
Mycoplasma pneumoniae Legionella pneumophilia Bordetella pertussis Chlamydophila pneumoniae |
QIAstat-Dx SARS-CoV-2/Flu A/B/RSV Panel: Qualitative test to analyze 4 targets for common respiratory pathogens to support efforts to provide accessible testing to meet the demands of the COVID-19 outbreak.
| QIAstat-Dx SARS-CoV-2/Flu A/B/RSV Panel – 4 viral targets |
|---|
| Viruses |
|
SARS-CoV-2 Influenza A Influenza B Respiratory syncytial virus A+B |
QIAstat-Dx Gastrointestinal Panel: Qualitative test to analyze 24 targets for common pathogens causing gastrointestinal infections.
| QIAstat-Dx Gastrointestinal Panel – 24 bacterial, viral and parasitic targets | |||
|---|---|---|---|
| Bacteria | Viruses | Parasites | |
|
Campylobacter (C. jejuni, C. upsaliensis, C. coli) Clostridium difficile (toxin A/B) Enteroaggregative E. coli (EAEC) Shigella/Enteroinvasive E. coli (EIEC) Enteropathogenic E. coli (EPEC) Enterotoxigenic E. coli (ETEC) lt/st Plesiomonas shigelloides |
Salmonella spp. Shiga-like toxin producing E.coli (STEC) stx1/stx2 Shiga-like toxin producing E.coli (STEC) O157:H7 Vibrio vulnificus Vibrio parahaemolyticus Vibrio cholerae Yersinia enterocolitica |
Adenovirus F40/41 Astrovirus Norovirus (GI) Norovirus (GII) Rotavirus A Sapovirus (GI, GII, GIV, GV) |
Cryptosporidium Cyclospora cayetanensis Entamoeba histolytica Giardia lamblia |
QIAstat-Dx Gastrointestinal Panel 2: Qualitative test to analyze 23 targets for common pathogens causing gastrointestinal infections, including differentiation of Shiga-like toxin producing E. coli (STEC) stx1 and stx2.
| QIAstat-Dx Gastrointestinal Panel 2 – 23 targets, corresponding to 22 bacterial, viral and parasitic pathogens | |||
|---|---|---|---|
| Bacteria | Viruses | Parasites | |
|
Campylobacter (C. jejuni, C. upsaliensis, C. coli) Clostridium difficile (toxin A/B) Enteroaggregative E. coli (EAEC) Shigella/Enteroinvasive E. coli (EIEC) Enteropathogenic E. coli (EPEC) Enterotoxigenic E. coli (ETEC) lt/st Plesiomonas shigelloides |
Salmonella spp. Shiga-like toxin-producing E. coli (STEC) stx1 and stx2 (including specific identification of E. coli O157 serogroup within STEC)*** Vibrio vulnificus Vibrio parahaemolyticus Vibrio cholerae Yersinia enterocolitica |
Adenovirus F40/41 Astrovirus Norovirus (GI, GII) Rotavirus A Sapovirus (GI, GII, GIV, GV) |
Cryptosporidium Cyclospora cayetanensis Entamoeba histolytica Giardia lamblia |
QIAstat-Dx Meningitis/Encephalitis Panel: Qualitative test to analyze 15 targets for common pathogens causing central nervous system infections (meningitis and encephalitis).
| QIAstat-Dx Meningitis/Encephalitis Panel – 15 bacterial, viral and fungal targets | ||
|---|---|---|
| Bacteria | Viruses | Fungi |
|
Escherichia coli K1 Haemophilus influenzae Listeria monocytogenes Neisseria meningitidis (encapsulated) Streptococcus agalactiae Streptococcus pneumoniae Mycoplasma pneumoniae Streptococcus pyogenes |
Enterovirus Herpes simplex virus 1 Herpes simplex virus 2 Human herpes virus 6 Human parechovirus Varicella zoster virus |
Cryptococcus neoformans/gattii **** |
Resources
Kit Handbooks (8)
Safety Data Sheets (5)
Instrument User Manuals (6)
Application Notes (1)
Protocol Files (6)
Software User Guides (2)
Quick-Start Protocols (1)
Operating Software (5)
Additional Resources (1)
Brochures & Guides (2)